Cargando…
Hyperinflammation and the utility of immunomodulatory medications in children with COVID-19
The rapid spread of SARS-CoV-2 infection globally coupled with the relatively high case-fatality rate has led to immediate need for therapeutic intervention to prevent and treat COVID-19 disease. There is accumulating evidence that morbidity and mortality in COVID-19 may be exacerbated by a dysregul...
Autores principales: | Tanner, Tamara, Wahezi, Dawn M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387280/ https://www.ncbi.nlm.nih.gov/pubmed/32792288 http://dx.doi.org/10.1016/j.prrv.2020.07.003 |
Ejemplares similares
-
Immunopathology of Hyperinflammation in COVID-19
por: Gustine, Joshua N., et al.
Publicado: (2021) -
Management of hyperinflammation in COVID-19 patients
por: Suberviola, Borja, et al.
Publicado: (2022) -
COVID-19 Hyperinflammation: What about Neutrophils?
por: Didangelos, Athanasios
Publicado: (2020) -
Frontal encephalopathy related to hyperinflammation in COVID-19
por: Cani, Ilaria, et al.
Publicado: (2020) -
Delving beneath the surface of hyperinflammation in COVID-19
por: Reddy, Kiran, et al.
Publicado: (2020)